Document is current
Any future updates will be listed below
-
Authors
Martró, Elisa
Domínguez-Hernández, Raquel
Forero, Venus
Gómez i Prat, Jordi
Not, Anna
Manzanares-Laya, Sandra
Montoro, Marcos
Gómez-Barrera, Manuel
Buti, Maria
Casabona, Jordi
Majó, Xavier
Colom, Joan
-
Funding
Funding for this research was provided by:
Instituto de Salud Carlos III (PI19/0568)
Instituto de Salud Carlos III, Fondo Social Europeo (FI20/00211)
Gilead Sciences, S.L.
- License Information
-
More Information
Article History
Received: 5 March 2026
Accepted: 11 May 2026
First Online: 20 May 2026
Declarations
:
: EM has received lecture fees and research grants from Abbott GmbH & Co.K.G., Gilead Sciences, Cepheid and Abbvie, outside of the submitted work. RDH and MGB are employees of Pharmacoeconomics & Outcomes Research Iberia (PORIB), a consulting firm specializing in the economic evaluation of health care interventions that has received financing for the development of the project that is not conditional upon the results. MB: has received lecture fees and research grants from Abbvie, GSK and Gilead Sciences, outside of the submitted work. VF, JG, AN, SML, MM, JC, XM and JC declare no competing interest.
